Patents by Inventor Harvey Jacobs

Harvey Jacobs has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20140196770
    Abstract: In at least one aspect of this disclosure, a photovoltaic module includes a frame, at least one photovoltaic cell disposed on the frame, a photovoltaic junction box electrically connected to the at least one photovoltaic cell and having a first photovoltaic junction box terminal and a second a photovoltaic junction box terminal, a first frame terminal electrically connected to the first photovoltaic junction box terminal via a first wire disposed within the frame, a second frame terminal electrically connected to the second photovoltaic junction box terminal via a second wire disposed within the frame, a third frame terminal, and a fourth frame terminal electrically connected to the third frame terminal via a third wire.
    Type: Application
    Filed: January 17, 2014
    Publication date: July 17, 2014
    Applicant: University of Central Florida Research Foundation, Inc.
    Inventor: Earl Harvey Jacobs, IV
  • Publication number: 20010010820
    Abstract: A method for delaying onset of insulin dependent diabetes mellitus (IDDM) in an individual predisposed to developing the disease is disclosed. The method comprises administering a composition comprising an immunologically effective monoclonal antibody or fragment thereof against glutamic acid decarboxylase (GAD) coupled to a nonimmunogenic hydrophilic polymer that provides a hydration shell around the monoclonal antibody for inhibiting immune recognition thereof. Poly(ethylene glycol) is a preferred polymer. A method of reducing insulitis in an IDDM patient and a composition therefor are also described.
    Type: Application
    Filed: December 29, 1998
    Publication date: August 2, 2001
    Inventors: HARVEY JACOBS, SUNG WAN KIM, VIRGINIE MENARD
  • Patent number: 5853723
    Abstract: A method for delaying onset of insulin dependent diabetes mellitus (IDDM) in an individual predisposed to developing the disease is disclosed. The method comprises administering a composition comprising an immunologically effective monoclonal antibody or fragment thereof against glutamic acid decarboxylase (GAD) coupled to a nonimmunogenic hydrophilic polymer that provides a hydration shell around the monoclonal antibody for inhibiting immune recognition thereof. Poly(ethylene glycol) is a preferred polymer. A method of reducing insulitis in an IDDM patient and a composition therefor are also described.
    Type: Grant
    Filed: September 20, 1996
    Date of Patent: December 29, 1998
    Assignee: University of Utah Research Foundation
    Inventors: Harvey Jacobs, Sung Wan Kim, Virginie Menard